Abiopharma

Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) Announces Executive and Board Changes Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) announced changes to its leadership team and board of directors. Directors or was appointed. The position includes: Audit Committee, Compensation Committee, Governance Committee, audit committee, Nominating and Corporate Governance Committee. The change is effective as of June 5, 2022. Executive Changes Details:

• Personnel Involved: Directors or, Certain Officers, Certain Directors, Matthew Angel, Interim President, Nicholas Singer, Treasurer and, Secretary and
• Actions: Appointed, Elected, Departed
• Committee Assignments: Audit Committee, Compensation Committee, Governance Committee, audit committee, Nominating and Corporate Governance Committee